Cancer Center Associate Director and Chief of Hematology/Oncology José Baselga, MD, PhD, continues our quest to bring the most promising targeted therapies from the bench to the bedside.
A look to the future of personalized medicine
José Baselga, MD, PhD
In July 2010, the Massachusetts General Hospital Cancer Center welcomed new Chief of Hematology/Oncology and Associate Director, José Baselga, MD, PhD. Dr. Baselga has since established a strong research presence at the Cancer Center focused on discovering and improving targeted therapies, with a particular emphasis on breast cancer.
Dr. Baselga’s work will build upon our efforts to integrate early-phase clinical and translational research with advanced, personalized patient care. Some highlights of his work include:
With Dr. Baselga now leading translational and early-phase clinical research, the Mass General Cancer Center is prepared to aggressively advance the search for targeted anti-cancer agents and identify new therapies for treatment-resistant cancers.
Learn more about how Dr. Baselga’s work is advancing personalized medicine:
For more about targeted therapies and innovative treatments at the Cancer Center:
U.S. News & World Report ranks Mass General #2 in the nation and #1 in New England based on our quality of care, patient safety and reputation in 16 clinical specialties.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.